Collaboration to reduce cancer incidence and mortality in Philadelphia
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
This study at the Sidney Kimmel Comprehensive Cancer Center is bringing together experts from different fields to find better ways to understand and treat cancer, especially for people in the Greater Philadelphia area, so that patients can access new treatments and clinical trials that come from this teamwork.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11252679 on NIH RePORTER |
What this research studies
This research initiative at the Sidney Kimmel Comprehensive Cancer Center aims to harness collaborative expertise across various research disciplines to tackle cancer more effectively. By integrating basic, clinical, and population research, the project seeks to enhance the understanding and treatment of cancer, particularly in the diverse communities of Greater Philadelphia. Patients may benefit from innovative treatments and clinical trials that arise from this collaborative approach, which emphasizes translating laboratory discoveries into practical applications in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with advanced cancers or those living in the Greater Philadelphia area who are seeking new treatment options.
Not a fit: Patients with early-stage cancers or those outside the catchment area may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in cancer incidence and mortality rates, improving outcomes for patients.
How similar studies have performed: Previous collaborations in cancer research have shown success in improving treatment outcomes, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Johnson, Jennifer — Thomas Jefferson University
- Study coordinator: Johnson, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.